Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - TriPath Imaging, Inc. (NasdaqNM:TPTH)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials
Location
780 Plantation Drive
Burlington, NC 27215
Phone: (336) 222-9707
Fax: (336) 222-8819
Email: info@tripathimaging.com
Employees (last reported count): 170
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Technology
 ·Industry: Scientific & Technical Instr.
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 54%
·Institutional: 39% (85% of float)
(76 institutions)
·Net Inst. Buying: 2.12M shares (+12.63%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
TriPath Imaging, Inc. develops, manufactures and markets proprietary products for cancer cell diagnosis, cytology and histopathology. TriPath Imaging manufactures and sells products developed from its proprietary technologies and intellectual property. These include United States Food and Drug Administration (FDA)-approved products designed to automate the screening for cancer of the uterine cervix, including the AutoCyte Prep System and the AutoPap Primary Screening System. In addition, the Company has developed the extended Slide Wizard line of products, the modules for which include an FDA-approved method for automating measurement of antinuclear antibodies, as well as research applications in histopathology, a system for the transmission and interpretation of tissue specimens via remote telecommunication and the AutoCyte Image Management and Archiving System, a software based storage and retrieval system for microscopic images.
More from Market Guide: Expanded Business Description

Financial Summary
TriPath Imaging develops, manufactures and markets the only integrated automated sample preparation and image analysis system to support cytology professionals in cervical cancer screening. For the six months ended 6/30/01, net sales fell less than 1% to $15.4 million. Net loss fell 6% to $7.4 million. Revenues reflect reduced AutoPap related sales. Lower loss reflects decreased general/administrative expenses and reduced interest expenses.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY1999 Compensation
PayExer

James Powell, M.D., 61
Chairman
$181K--  
Paul Sohmer
Pres, CEO
--  --  
David Robison, 49
VP of Operations
170K--  
Roger Martin, 52
VP, Sales and Marketing
--  --  
Thomas Gahm, Ph.D., 43
VP of Cytology R&D
178K$128K
Dollar amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:TPTHAs of 31-Aug-2001
Price and Volume
52-Week Low
on 9-Apr-2001
$2.90 
Recent Price$5.00 
52-Week High
on 2-Feb-2001
$13.00 
Beta0.08 
Daily Volume (3-month avg)180.6K
Daily Volume (10-day avg)98.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y]
52-Week Change-39.9%
52-Week Change
relative to S&P500
-19.3%
Share-Related Items
Market Capitalization$186.4M
Shares Outstanding37.3M
Float17.2M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$2.18 
Earnings (ttm)-$0.53 
Earnings (mrq)-$0.12 
Sales (ttm)$1.01 
Cash (mrq)$1.32 
Valuation Ratios
Price/Book (mrq)2.30 
Price/EarningsN/A 
Price/Sales (ttm)4.94 
Income Statements
Sales (ttm)$32.5M
EBITDA (ttm)-$10.8M
Income available to common (ttm)-$16.9M
Profitability
Profit Margin (ttm)-51.9%
Operating Margin (ttm)-53.2%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-21.59%
Return on Equity (ttm)-26.61%
Financial Strength
Current Ratio (mrq)6.27 
Debt/Equity (mrq)0.05 
Total Cash (mrq)$45.4M
Short Interest
As of 8-Aug-2001
Shares Short633.0K
Percent of Float3.7%
Shares Short
(Prior Month)
754.0K
Short Ratio2.93 
Daily Volume216.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.